Business Context and Reporting Period
Company: NETSTREIT Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: February 11, 2026 (Event Date: February 13, 2026)
Event: Completion of a public offering of common stock involving forward sale agreements.
Key Financial Metrics and Transaction Details
- Shares Issued: 12,627,000 shares of Common Stock ($0.01 par value).
- Offering Price: $19.00 per share.
- Total Gross Proceeds (Potential): Approximately $239.9 million (12,627,000 shares x $19.00).
- Underwriters: Wells Fargo Securities, LLC and BofA Securities, Inc.
- Forward Purchasers/Counterparties: Wells Fargo Bank, National Association and Bank of America, N.A.
- Option Exercise: Underwriters exercised a 30-day option in full to purchase an additional 1,647,000 shares.
Material Changes and Transaction Structure
This filing reports a significant capital raise structured through forward sale agreements. Key structural details include:
- Immediate Proceeds: The Company will not initially receive proceeds from the sale of shares by the forward purchasers.
- Settlement Mechanism: The Company expects to physically settle the Forward Sale Agreements by delivering shares of Common Stock on one or more forward settlement dates occurring no later than February 11, 2027.
- Alternative Settlement: The Company retains the option to cash settle or net share settle obligations if deemed in its best interest. Cash settlement could result in the Company receiving no proceeds or owing cash to the counterparty.
Guidance, Risks, and Contingencies
Management Commentary: The transaction was executed pursuant to an underwriting agreement dated February 11, 2026, and a registration statement on Form S-3 effective August 12, 2024.
Risks and Contingencies:
- Settlement Risk: Proceeds are contingent upon the settlement of forward agreements, which may be delayed until 2027.
- Cash Settlement Risk: If the Company elects to cash settle, it may not receive any proceeds and could incur a cash obligation to the forward counterparties.
- Dilution: The issuance of 12,627,000 shares represents a significant increase in outstanding common stock.
Investor Verification Checklist
- Verify the exact settlement dates for the Forward Sale Agreements to determine when cash proceeds will be recognized.
- Review the full text of the Forward Sale Agreements (Exhibits 1.1 through 1.4) to understand specific triggers for cash settlement versus physical delivery.
- Confirm the impact of the 12,627,000 new shares on existing shareholder dilution and earnings per share.
- Monitor future filings for any election by the Company to cash settle the agreements, which would alter the expected capital inflow.